• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非透析慢性肾脏病患者心房颤动的患病率及其预测因素。

Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.

机构信息

Department of Medicine, University of Illinois at Chicago, Advocate Christ Medical Center, Oak Lawn, Illinois 60453, USA.

出版信息

Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81. doi: 10.2215/CJN.03170509. Epub 2009 Dec 10.

DOI:10.2215/CJN.03170509
PMID:20007681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2827597/
Abstract

BACKGROUND AND OBJECTIVES

Chronic kidney disease (CKD) increases systemic inflammation, which is implicated in development and maintenance of atrial fibrillation (AF); therefore, we hypothesized that the prevalence of AF would be increased among nondialysis patients with CKD. This study also reports independent predictors of the presence of AF in this population.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A retrospective, cross-sectional analysis of 1010 consecutive nondialysis patients with CKD from two community-based hospitals was conducted. Estimated GFRs (eGFRs) were calculated using the Modification of Diet in Renal Disease (MDRD) equation. Multivariate logistic regression was used to determine independent predictors.

RESULTS

Of 1010 nondialysis patients with CKD, 214 (21.2%) had AF. Patients with AF were older than patients without AF (76 +/- 11 versus 63 +/- 15 yr). The prevalence of AF among white patients (42.7%) was higher than among black patients (12.7%) or other races (5.7%). In multivariate analyses, age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure were identified as independent predictors of the presence of AF. Although serum high-sensitivity C-reactive protein levels were elevated in our population (5.2 +/- 7.4 mg/L), levels did not correlate with the presence of AF or with eGFR. Finally, eGFR did not correlate with the presence of AF in our population.

CONCLUSIONS

The prevalence of AF was increased in our population, and independent predictors were age, white race, increasing left atrial diameter, lower systolic BP, and congestive heart failure.

摘要

背景与目的

慢性肾脏病(CKD)会引起全身炎症,这与房颤(AF)的发生和维持有关;因此,我们假设非透析 CKD 患者的 AF 患病率会增加。本研究还报告了该人群中 AF 存在的独立预测因素。

设计、设置、参与者和测量:对来自两家社区医院的 1010 例连续非透析 CKD 患者进行回顾性、横断面分析。使用肾脏病饮食改良公式(MDRD)计算估计肾小球滤过率(eGFR)。使用多变量逻辑回归确定独立预测因素。

结果

在 1010 例非透析 CKD 患者中,有 214 例(21.2%)患有 AF。患有 AF 的患者比没有 AF 的患者年龄更大(76 +/- 11 岁 vs 63 +/- 15 岁)。白人患者(42.7%)的 AF 患病率高于黑人患者(12.7%)或其他种族患者(5.7%)。多变量分析表明,年龄、白种人、左心房直径增大、收缩压降低和充血性心力衰竭是 AF 存在的独立预测因素。尽管我们人群中的血清高敏 C 反应蛋白水平升高(5.2 +/- 7.4 mg/L),但水平与 AF 的存在或 eGFR 均无相关性。最后,在我们的人群中,eGFR 与 AF 的存在无关。

结论

在我们的人群中,AF 的患病率增加,独立预测因素为年龄、白种人、左心房直径增大、收缩压降低和充血性心力衰竭。

相似文献

1
Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.非透析慢性肾脏病患者心房颤动的患病率及其预测因素。
Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81. doi: 10.2215/CJN.03170509. Epub 2009 Dec 10.
2
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.美国成年人慢性肾脏病与心房颤动的相关性:卒中地理和种族差异原因(REGARDS)研究。
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):26-32. doi: 10.1161/CIRCEP.110.957100. Epub 2010 Nov 13.
3
[Chronic renal disease and atrial fibrillation in patients with chronic heart failure].[慢性心力衰竭患者的慢性肾病与心房颤动]
Ter Arkh. 2009;81(12):23-6.
4
Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者肾小球滤过率降低及左心房淤血标志物
Cardiology. 2013;124(1):3-10. doi: 10.1159/000345434. Epub 2012 Dec 13.
5
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).慢性肾脏病与常见的心房颤动:慢性肾脏病预后队列研究(CRIC)。
Am Heart J. 2010 Jun;159(6):1102-7. doi: 10.1016/j.ahj.2010.03.027.
6
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).肾小球滤过率估计值对接受维生素 K 拮抗剂治疗的非常老年患者出血风险的影响。EPICA 研究代表 FCSA(意大利抗凝临床学会)的结果。
Thromb Haemost. 2012 Jun;107(6):1100-6. doi: 10.1160/TH11-10-0721. Epub 2012 Apr 26.
7
[Prevalence and risk factors of atrial fibrillation in hospitalized patients with chronic kidney disease].[慢性肾脏病住院患者心房颤动的患病率及危险因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2013 May;41(5):390-3.
8
Comparison of atrial fibrillation in CKD and non-CKD populations: A cross-sectional analysis from the Kailuan study.慢性肾脏病与非慢性肾脏病人群中心房颤动的比较:来自开滦研究的横断面分析。
Int J Cardiol. 2019 Feb 15;277:125-129. doi: 10.1016/j.ijcard.2018.11.098. Epub 2018 Nov 17.
9
Five-Year Change in the Renal Function After Catheter Ablation of Atrial Fibrillation.房颤导管消融术后 5 年肾功能变化。
J Am Heart Assoc. 2019 Sep 3;8(17):e013204. doi: 10.1161/JAHA.119.013204. Epub 2019 Aug 31.
10
Glomerular filtration rate in patients with atrial fibrillation on warfarin treatment: a subgroup analysis from the AURICULA registry in Sweden.华法林治疗的心房颤动患者的肾小球滤过率:来自瑞典 AURICULA 登记处的亚组分析。
Thromb Res. 2011 Oct;128(4):341-5. doi: 10.1016/j.thromres.2011.04.022. Epub 2011 May 28.

引用本文的文献

1
Cardiovascular disease risk assessment, exercise training, and management of complications in patients with chronic kidney disease.慢性肾病患者的心血管疾病风险评估、运动训练及并发症管理
Int J Cardiol Cardiovasc Risk Prev. 2025 Mar 6;25:200386. doi: 10.1016/j.ijcrp.2025.200386. eCollection 2025 Jun.
2
High premature atrial complex burden and risk of renal function decline.高过早心房复合波负荷与肾功能下降风险
Clin Kidney J. 2024 Jul 4;17(8):sfae208. doi: 10.1093/ckj/sfae208. eCollection 2024 Aug.
3
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients.慢性肾病患者血清氯水平与房颤风险之间的负相关关系。
Clin Kidney J. 2024 May 13;17(8):sfae137. doi: 10.1093/ckj/sfae137. eCollection 2024 Aug.
4
Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.肾功能不全抗凝治疗专题:复杂情况下的抗凝治疗。
Thromb Res. 2024 Sep;241:109097. doi: 10.1016/j.thromres.2024.109097. Epub 2024 Jul 23.
5
A Systematic Review on the Effectiveness of Machine Learning in the Detection of Atrial Fibrillation.关于机器学习在心房颤动检测中有效性的系统评价
Curr Cardiol Rev. 2025;21(1):e310724232529. doi: 10.2174/011573403X293703240715104503.
6
Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020.2010-2020 年,英国伴有和不伴有慢性肾脏病的老年房颤患者抗凝药物起始模式。
Open Heart. 2024 Jan 31;11(1):e002515. doi: 10.1136/openhrt-2023-002515.
7
Effectiveness and safety of apixaban and rivaroxaban warfarin in patients with atrial fibrillation and chronic kidney disease.阿哌沙班和利伐沙班相对于华法林在心房颤动合并慢性肾脏病患者中的有效性和安全性
World J Nephrol. 2023 Dec 25;12(5):132-146. doi: 10.5527/wjn.v12.i5.132.
8
Dialysis Modality, Transplant Characteristics, and Incident Atrial Fibrillation After Kidney Transplant: An Observational Study Using USRDS Data.透析方式、移植特征与肾移植后新发房颤:一项使用美国肾脏数据系统(USRDS)数据的观察性研究
Kidney Med. 2023 Oct 12;6(1):100741. doi: 10.1016/j.xkme.2023.100741. eCollection 2024 Jan.
9
Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.阿哌沙班剂量与伴有严重慢性肾脏病的心房颤动患者安全性和有效性结局的相关性。
Circulation. 2023 Nov 7;148(19):1445-1454. doi: 10.1161/CIRCULATIONAHA.123.065614. Epub 2023 Sep 8.
10
Cardiovascular and renal outcomes in patients with atrial fibrillation and stage 4-5 chronic kidney disease receiving direct oral anticoagulants: a multicenter retrospective cohort study.接受直接口服抗凝剂的伴有心房颤动和 4-5 期慢性肾脏病患者的心血管和肾脏结局:一项多中心回顾性队列研究。
J Thromb Thrombolysis. 2024 Jan;57(1):89-100. doi: 10.1007/s11239-023-02885-9. Epub 2023 Aug 21.

本文引用的文献

1
Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.一组长期血液透析患者的心房颤动与发病率和死亡率
Am J Kidney Dis. 2008 Feb;51(2):255-62. doi: 10.1053/j.ajkd.2007.10.034.
2
Inflammatory markers according to types of atrial fibrillation.根据心房颤动类型的炎症标志物。
Int J Cardiol. 2007 Aug 21;120(2):193-7. doi: 10.1016/j.ijcard.2006.09.015. Epub 2007 Jan 19.
3
Frequency of atrial fibrillation and factors related to its development in dialysis patients.透析患者心房颤动的发生率及其发生相关因素
Int J Cardiol. 2006 Jan 4;106(1):47-51. doi: 10.1016/j.ijcard.2004.12.048.
4
Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.长期血液透析患者人群中心房颤动的患病率及相关因素
Am J Kidney Dis. 2005 Nov;46(5):897-902. doi: 10.1053/j.ajkd.2005.07.044.
5
Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂预防心房颤动:一项荟萃分析。
J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9. doi: 10.1016/j.jacc.2004.11.070.
6
Obesity and the risk of new-onset atrial fibrillation.肥胖与新发心房颤动的风险
JAMA. 2004 Nov 24;292(20):2471-7. doi: 10.1001/jama.292.20.2471.
7
Association of atrial fibrillation and obstructive sleep apnea.心房颤动与阻塞性睡眠呼吸暂停的关联。
Circulation. 2004 Jul 27;110(4):364-7. doi: 10.1161/01.CIR.0000136587.68725.8E. Epub 2004 Jul 12.
8
Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study.心力衰竭患者中心房颤动患病率的种族差异:心力衰竭的流行病学、实践、结局及成本(EPOCH)研究
J Am Coll Cardiol. 2004 Feb 4;43(3):429-35. doi: 10.1016/j.jacc.2003.09.035.
9
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.中重度慢性肾病患者氧化应激和炎症的患病率增加。
Kidney Int. 2004 Mar;65(3):1009-16. doi: 10.1111/j.1523-1755.2004.00465.x.
10
Inflammation as a risk factor for atrial fibrillation.炎症作为心房颤动的一个风险因素。
Circulation. 2003 Dec 16;108(24):3006-10. doi: 10.1161/01.CIR.0000103131.70301.4F. Epub 2003 Nov 17.